Sign up to save your podcasts
Or
Share Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors
We love to hear from our listeners. Send us a message.
Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Freakonomics Radio
32,081 Listeners
Planet Money
30,688 Listeners
Motley Fool Money
3,223 Listeners
The Knowledge Project
2,672 Listeners
Nature Podcast
762 Listeners
HBR IdeaCast
180 Listeners
Immune
277 Listeners
The Readout Loud
325 Listeners
BioCentury This Week
33 Listeners
People I (Mostly) Admire
2,099 Listeners
Raising Health
146 Listeners
Biotech Hangout
19 Listeners
NEJM AI Grand Rounds
56 Listeners
ASGCT Podcast Network
16 Listeners
HBR On Leadership
167 Listeners